Benhalima T, Mokhtari M, Ferfera-Harrar H (2024) Synergistic adsorption/photodegradation effect for effective removal of crystal Violet dye and Acetamiprid pesticide using Fe3 + cross-linked ternary carboxymethyl cellulose/polyaniline/TiO 2 photocomposites
In these studies, semaglutide demonstrated superior and sustained glycemic control and weight loss than all the other comparators evaluated
Ma X, Liu Z, Ilyas I et al (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
In addition to weight reduction, the Phase 2 trial reported improvements in several cardiometabolic markers, including: Reductions in waist circumference Improvements in blood pressure Favourable changes in lipid profiles Reductions in fasting glucose and insulin resistance Increases in heart rate were also observed, consistent with findings seen with other incretin-based therapies These findings suggest that retatrutide may offer broader metabolic benefits beyond weight loss alone, which is particularly relevant for patients with obesity-related comorbidities such as type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), or elevated cardiovascular risk
